The species that cannot act as an ambidentate ligand is:

1.	\(\mathrm{CN}^-\)	2.	\(\mathrm{NO}^-_2\)
3.	\(\mathrm{SCN}^-\)	4.	\(\mathrm{NH_3}\)

The correct statement, among the following, regarding [Mn(CN)₆]^3- is:

1. It is sp³d² hybridised and octahedral in shape

2. It is sp³d² hybridised and tetrahedral in shape

3. It is d²sp³ hybridised and octahedral in shape

4. It is dsp² hybridised and square planar in shape

The correct statement among the following about [Co(CN)₆]^3- is :

The complex that is used as an anticancer agent is:

1. mer-[Co(NH₃)₃Cl₃         

2. cis-[PtCl₂(NH₃)₂]

3. cis-K₂[PtCl₂ Br₂]           

4. Na₂CoCl₄

[Co(NH₃)₄(NO₂)₂]Cl can show:

The electronic arrangement of an octahedral complex with a ${\mathrm{d}}^4$ configuration, if ∆₀ < pairing energy is:

1. ${\mathrm{t}}_{2\mathrm{g}}^4{\mathrm{e}}_{\mathrm{g}}^0$                       

2. ${\mathrm{e}}_{\mathrm{g}}^4{\mathrm{t}}_{2\mathrm{g}}^0$               

3. ${\mathrm{t}}_{2\mathrm{g}}^3{\mathrm{e}}_{\mathrm{g}}^1$           

4. ${\mathrm{e}}_{\mathrm{g}}^2{\mathrm{t}}_{2\mathrm{g}}^2$

The incorrect option among the following is:

The correct IUPAC name for Mn₃(CO)₁₂ is:

1. Dodecacarbonylmanganate(0)

2. Dodecacarbonylmanganate(II)

3. Dodecacarbonyltrimanganese(0)

4. Manganicdodecacarbonyl0)

The denticity of EDTA is:

IUPAC name of [Pt(NH₃)₃(Br)(NO₂)Cl]Cl is: